Axe Compute Inc AI Stock Analysis
Axe Compute Inc (S1K0) AI Stock Analysis
Axe Compute Inc
(Frankfurt:S1K0)
No summary available
Axe Compute Inc (S1K0) vs. iShares MSCI Germany ETF (EWG)
- Market Cap
- EUR 65.01M
- Dividend Yield
- ―
- Average Volume (3M)
- 666
- Price to Earnings (P/E)
- -0.2
- Beta (1Y)
- 1.84
- Revenue Growth
- 1230.88%
- EPS Growth
- 69.04%
- Country
- Germany
- Employees
- 14
- Sector
- Technology
- Sector Strength
- 61
- Industry
- Software - Infrastructure
Axe Compute Inc Business Overview & Revenue Model
Company Description
Headquartered in Pittsburgh, Pennsylvania, Axe Compute Inc., established in 2002 and formerly known as Predictive Oncology Inc. until its December 2025 renaming, is an enterprise that leverages profound scientific insights and artificial intelligence...
Axe Compute Inc Earnings Call Summary
The call was strongly positive, led by 125% sequential revenue growth, the first quarter of positive operating income and net income, more than $3 billion of signed contract value, over 18,000 GPUs in delivery and a qualified pipeline that increased 118% to $14.1 billion. The main negative factors were the $2.3 million adjusted EBITDA loss, the absence of Build revenue in Q3, reliance on noncash gains in reported profitability, the deferred purchase price liability and the fact that the pipeline is not yet signed contract value.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Management said the signed book is expected to be fully deployed across Q4 2026 and into 2027, and that remains the target 3 months later; revenue from some of the new contracts already started in Q3, the rest activates through Q4 and early Q1, and it is expected to fully ramp to steady state over the next 2 quarters. The fourth quarter is about bringing those builds online and turning signed contracts into revenue, with the run rate stepping up cluster by cluster through that window. The Georgia contract was extended to 5 years through 2031, with approximately $352.6 million of revenue expected over the life of the contract, while the 4 factories comprise over 18,000 NVIDIA B300 GPUs, including 2,304 in Georgia, over 2,000 in Sweden, over 9,000 in the U.S. large cluster and over 4,600 in the U.S. expansion cluster; power requirements are 5 megawatts, 5 megawatts, 20 megawatts and 10 megawatts, respectively, with a large amount of double-digit megawatts also secured.
Axe Compute Inc Risk Analysis
Axe Compute Inc disclosed 46 risk factors in its most recent earnings report. Axe Compute Inc reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
3 New RisksAxe Compute Inc Peers Comparison
Overall Rating
WOK43Neutral
GCTK39Underperform
FEMY28Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 61Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
| 43Neutral | $5.16M | -0.01 | -18.55% | ― | ― | ― | |
| 39Underperform | $221.43K | -0.00 | -2135.52% | ― | ― | 99.51% | |
| 28Underperform | $10.91M | -0.32 | -114.48% | ― | -4.21% | 78.58% |
* Technology Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DE:S1K0 | Axe Compute Inc. | 6.35 | 1.03 | 19.45% | |
| GCTK | Glucotrack, Inc. | 0.18 | -143.82 | -99.87% | |
| FEMY | Femasys, Inc. | 1.24 | -17.14 | -93.26% | |
| WOK | WORK Medical Technology Group LTD | 1.09 | -41398.90 | -100.00% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
